Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000133148 | SCV002769699 | likely benign | Rett syndrome | 2022-10-11 | reviewed by expert panel | curation | The p.Pro173Ala variant in MECP2 (NM_004992.3) has been reported in an individual with a clinical phenotype suggestive of Rett syndrome; this individual was reported to have a second variant in MECP2 that was classified as Pathogenic (PMID 11241840). The p.Pro173Ala variant in MECP2 (NM_004992.3) is observed in at least 2 unaffected individuals (internal database - GeneDx; internal database - Invitae) (BS2). The p.Pro173Ala variant is found in at least 2 patients with an alternate molecular basis of disease (internal database - GeneDx; internal database - Invitae) (BP5). The p.Pro173Ala variant in MECP2 is present in 3 female and 2 male individual(s) in gnomAD (0.0024%) (not sufficient to meet BS1 criteria). In summary, the p.Pro173Ala variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP5). |
Ce |
RCV000513430 | SCV000609421 | uncertain significance | not provided | 2017-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000766084 | SCV000897559 | uncertain significance | Severe neonatal-onset encephalopathy with microcephaly; Syndromic X-linked intellectual disability Lubs type; X-linked intellectual disability-psychosis-macroorchidism syndrome; Rett syndrome; Autism, susceptibility to, X-linked 3 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000513430 | SCV001764578 | likely benign | not provided | 2019-05-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 11241840) |
Labcorp Genetics |
RCV002055855 | SCV002322795 | likely benign | Severe neonatal-onset encephalopathy with microcephaly | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Centre for Population Genomics, |
RCV000133148 | SCV004808751 | likely benign | Rett syndrome | 2024-03-14 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely benign. At least the following criteria are met: The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2). Variant is found in an individual with an alternate molecular basis of disease (BP5). |
Rett |
RCV000133148 | SCV000188140 | uncertain significance | Rett syndrome | 2002-09-05 | no assertion criteria provided | curation | |
Prevention |
RCV004532604 | SCV004712468 | likely benign | MECP2-related disorder | 2022-02-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |